| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |